Breaking a three-year silence by the medical and human rights community, a panel of doctors, attorneys, human rights professionals, university professors and ethics experts have called for an investigation into the use of mefloquine on detainees at Guantanamo Naval Prison. The prison camp had instituted in very early 2002 an unprecedented policy of administering full-treatment doses of mefloquine to all incoming detainees at Guantanamo. Complicating the report’s finding was the fact the man who signed off on the mefloquine policy, Captain Albert Shimkus, was also on the task force that investigated the medical ethical issues regarding interrogation that occupied the report.
|By: Jeff Kaye Friday November 15, 2013 2:20 am|
|By: Jeff Kaye Saturday August 20, 2011 6:53 pm|
On August 18, Senator Dianne Feinstein put out a press release indicating that the Department of Defense should consider taking the anti-malarial drug mefloquine, also known as Lariam, out of the DoD drug formulary as it is too dangerous. Feinstein also indicated the drug has been administered to military personnel without the safeguards put in place by a 2009 Department of Defense protocol. But the drug was also used in massive doses on all the Guantanamo detainees, an unprecedented application of the drug on prisoners for supposed preventative purposes.